Aneuploidy index in blood: A potential marker for early onset, androgen response, and metastasis in human prostate cancer

Urology

Volumn 53, Issue 2, 1999, Pages 381-385

  Ozen, Mustafa ^a   Hopwood, Vicki L ^a   Johnston, Dennis A ^a   Babaian, Richard J ^a   Logothetis, Christopher J ^a   Von Eschenbach, Andrew C ^a   Pathak, Sen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER STAGING; CHROMOSOME ABERRATION; CONTROLLED STUDY; EARLY DIAGNOSIS; HORMONE RESPONSE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONSET AGE; PERIPHERAL LYMPHOCYTE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ANEUPLOIDY; HUMANS; KARYOTYPING; LYMPHATIC METASTASIS; LYMPHOCYTES; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0032895242     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00487-7     Document Type: Article

References (21)

1. Gittes R.F. Carcinoma of the prostate. N Engl J Med. 324:1991;236-245.
2. Shankey V., Kallionemi O., Koslowski J.M., et al. Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry. 14:1993;497-500.
3. Alcaraz A., Takahashi S., Brown J.A., et al. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res. 54:1994;3998-4002.
4. Pathak S. Cytogenetic abnormalities in cancer with special emphasis on tumor heterogeneity . Cancer Metastasis Rev. 8:1990;299-318.
5. von Hasemann D. Ueber asymmetrische Zelltheilung in Epithelkrebsen und deren biologische Bedeutung. Virchows Arch Pathol Anat. 119:1890;299-326.
6. Li R., Yerganian G., Duesberg P., et al. Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. Proc Natl Acad Sci USA. 941:1997;14506-14511.
7. Pathak S. Chromosome banding techniques. J Reprod Med. 17:1976;25-28.
8. Zarr J.H. Biostatistical Analysis. 3rd ed. 1996;179-306 Prentice-Hall, Englewood Cliffs, NJ.
9. Pathak S., Dhaliwal M.K., Hopwood V.L. Genetic susceptibility, somatic mosaicism, and predisposition to human cancers. Anticancer Res. 9:1989;17-20.
10. Isaacs J.T. Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer. Am J Pathol. 150:1997;1511-1521.
11. Scardino P.T., Weaver R., Hudson M.A. Early detection of prostate cancer. Cancer Res. 54:1994;6249-6256.
12. Greene G.F., Kitadai Y., Pettaway C.A., et al. Correlation of metastasis related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am J Pathol. 150:1997;1511-1582.
13. Weidner N. Tumor angiogenesis review of current applications in tumor prognostication . Semin Diagn Pathol. 10:1993;302-313.
14. Furusato M., Watui S., Sasaki H., et al. Tumor angiogenesis in latent prostatic carcinoma. Br J Cancer. 70:1994;1244-1246.
15. Dong J.T., Lamb P.W., Rinker-Schaeffer C.W., et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11 2 . Science. 268:1995;884-886.
16. Ichikawa T., Nihei N., Suzuki H., et al. Suppression of metastasis of rat prostatic cancer by introducing human chromosome 8. Cancer Res. 54:1994;2299-2302.
17. Nihei N., Ichikawa T., Kawana Y., et al. Localization of metastasis suppressor gene(s) for rat prostatic cancer to the long arm of human chromosome 10. Genes Chromosom Cancer. 14:1995;112-119.
18. Rinker-Schaeffer C.W., Hawkins A.L., Ru N., et al. Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11. Consensus review of the clinical utility of DNA content cytometry in prostate cancer. Cytometry. 14:1993;497-500.
19. Ozen M., Multani A.S., Chang S.M., et al. Establishment of an in vitro cell model system to study human prostate carcinogenesis involvement of chromosome 5 in early stages of neoplastic transformation . Int J Oncol. 8:1996;883-888.
20. Ozen M., Navone N.M., Multani A.S., et al. Structural alterations of chromosome 5 in twelve human prostate cancer cell lines. Cancer Genet Cytogenet. 106:1998;105-109.
21. Young C.Y.F., Andrews P.E., Tindall D.J. Expression and androgenic regulation of human prostate-specific kallikreins. J Androl. 16:1995;97-99.